*Contributed for research and discussion.
Transgenic soya beans: economic implications for EU livestock sector
Article first published online: 12 APR 2011
© 2011 Blackwell Publishing Ltd
Quality Assurance and Safety of Crops & Foods
Volume 3, Issue 2, pages 54–62, June 2011
How to Cite
McFarlane, I., Park, J., Ceddia, G. and Phipps, R. (2011), Transgenic soya beans: economic implications for EU livestock sector. Quality Assurance and Safety of Crops & Foods, 3: 54–62. doi: 10.1111/j.1757-837X.2011.00096.x
- Issue published online: 18 MAY 2011
- Article first published online: 12 APR 2011
- Received 21 July 2010; revised 3 November 2010; accepted 29 November 2010.
- animal nutrition;
- feed grains;
- GM crops;
World oilseed trade consists of many closely substitutable commodities, with canola and cottonseed as possible alternatives to soya beans for many purposes. Transgenic events in all three crops have been widely adopted, particularly in North and South America, for compelling economic or agronomic reasons. Despite the close attention from organizations concerned about the potential consequences of transgenic crop adoption, there appears to be no substantiated evidence of transgenic DNA in meat or milk products when such crops are fed to livestock. The global area of these transgenic crops continues to increase. No transgenic canola, cotton or soya bean crops are permitted for commercial cultivation in Europe, and although transgenic feed resources are permitted for import, importers risk shipments being denied entry if the traces of an unauthorized transgenic crop are detected. These tight controls can mean that livestock farmers in the EU are disadvantaged due to restricted access to cheaper feed or higher feed costs, and they are thus loosing a degree of competitive advantage. This paper reviews the extent to which transgenic soya beans have become the ‘conventional’ method of cultivation elsewhere, and notes implications this has for livestock nutrition, traceability and economics within the EU. The paper concludes with discussion regarding the implications for the EU of delayed acceptance of newly available transgenic traits.